XML 27 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities    
Net loss $ (47,712) $ (43,341)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,407 3,137
Stock-based compensation 11,134 9,820
Forgiveness of notes receivable 1 4
Changes in operating assets and liabilities:    
Receivables (53) (159)
Prepaid expenses and other current assets 1,717 1,364
Accounts payable 813 (283)
Accrued personnel-related expenses, accrued clinical and development expenses, accrued interest on convertible subordinated notes and other current liabilities (3,488) (1,571)
Deferred rent 1,932 931
Deferred revenue (11,401) (10,400)
Other liabilities, non-current   (389)
Net cash used in operating activities (43,650) (40,887)
Cash flows from investing activities    
Purchases of property and equipment (2,763) (133)
Purchases of marketable securities (176,322) (103,861)
Sales of marketable securities 8,750  
Maturities of marketable securities 119,476 70,000
Release of restricted cash   417
Additions to notes receivable (140)  
Payments received on notes receivable 530 110
Net cash used in investing activities (50,469) (33,467)
Cash flows from financing activities    
Payments on note payable and capital lease (113) (89)
Proceeds from issuances of common stock, net 21,557 96,620
Net cash provided by financing activities 21,444 96,531
Net increase (decrease) in cash and cash equivalents (72,675) 22,177
Cash and cash equivalents at beginning of period 163,333 47,544
Cash and cash equivalents at end of period $ 90,658 $ 69,721